Results 51 to 60 of about 45,438 (256)

Research progress on biomarkers of traumatic brain injury

open access: yesAnimal Models and Experimental Medicine, EarlyView.
Traumatic brain injury: From primary insult to secondary neuroinflammation and degeneration. Abstract Traumatic brain injury (TBI) is a common disorder of the nervous system and has become a leading cause of death and disability worldwide, imposing a substantial burden on patients and their social circles. Its main symptoms include dyskinesia, language
Xuting Shen   +8 more
wiley   +1 more source

The role of experiential knowledge in the reproductive decision making of families genetically at risk : the case of spinal muscular atrophy [PDF]

open access: yes
This study reports on the analysis of 59 in-depth interviews conducted with people diagnosed with, or from families affected by, Spinal Muscular Atrophy (SMA).
Boardman, Felicity K.
core  

The Dynamics of Neurofilament Light Chain in Spinal Muscular Atrophy

open access: yesAnnals of Neurology, EarlyView.
Objective Newborn screening (NBS) for spinal muscular atrophy (SMA) facilitates early diagnosis and treatment for affected individuals. However, fluid biomarkers that provide early insights into disease activity and outcomes in a neonatal cohort and those unable to access (due to reimbursement criteria) or deferring immediate treatment are lacking ...
Arlene D'Silva   +13 more
wiley   +1 more source

Revisiting paravertebral muscles in European rabbits (Oryctolagus cuniculus) and European brown hares (Lepus europaeus) (Leporidae; Lagomorpha)

open access: yesThe Anatomical Record, EarlyView.
Abstract Domesticated European rabbits (Oryctolagus cuniculus) have long been chosen as laboratory model organisms. Despite this, there has been no definitive study of the vertebral musculature of wild rabbits. Relevant descriptions of well‐studied veterinary model mammals (such as dogs) are generally applicable, but not appropriate for a species ...
Nuttakorn Taewcharoen   +3 more
wiley   +1 more source

Proximal spinal muscular atrophy: current orthopedic perspective

open access: yes, 2013
Gerrit Haaker, Albert Fujak Department of Orthopaedic Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Abstract: Spinal muscular atrophy (SMA) is a hereditary neuromuscular disease of lower motor neurons that is ...
Fujak A, Haaker G
core  

Chronic Patellar Tendon Reconstruction Using Ipsilateral Peroneus Longus Autograft

open access: yesArthroscopy Techniques, EarlyView.
Abstract Chronic patellar tendon rupture is a rare and challenging injury that compromises knee extension and overall function. Conventional repair often requires augmentation or reconstruction using autografts, allografts, or synthetic materials, with most techniques involving transpatellar tunnels, which increase the risk of iatrogenic fracture. This
Daniel Vélez‐Díaz   +4 more
wiley   +1 more source

Arthroscopic Rotator Cuff Repair With Autologous Biologic Augmentation Using Biceps Tendon Redirection and Incorporation

open access: yesArthroscopy Techniques, EarlyView.
Abstract The long head of the biceps tendon is a valuable autologous tissue for biologic augmentation in rotator cuff repair. Redirecting the long head of the biceps tendon can enhance its role as a humeral head depressor, limiting superior humeral head migration, and improving rotator cuff force couple and shoulder biomechanics. Incorporating the long
Erel Ben‐Ari   +4 more
wiley   +1 more source

Anaesthetic Management of Spinal Muscular Atrophy For Laparoscopic Cholecystectomy

open access: yes, 2006
We report the anaesthetic management of a female patient with Spinal Muscular Atrophy (SMA) presented for laparoscopic cholecystectomy. In order to avoid prolonged recovery; we chose to use total intravenous anaesthesia (TIVA) with propofol and ...
Dr. E. Argyra / Dr. C. Staikou / Dr. G. Polymeneas / Dr. C. M. Markatou
core  

A rare case of spinal muscular atrophy: prenatal type 0

open access: yes, 2021
Spinal muscular atrophy (SMA) is a genetic disorder characterized by degeneration of the anterior horn cells leading to muscle atrophy and weakness. SMA is an autosomal recessive disorder in 95% of the cases.
Yordanova, Diana; Medical University of Varna   +2 more
core   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy